Stories tagged 'Polly A Newcomb'
Science to watch in 2018: From immunotherapy to gene therapy, big data to new tech
Fred Hutch experts lend their predictions for the coming year’s advances
Jan. 12, 2018 | By Rachel Tompa / Fred Hutch News Service
We asked Fred Hutch researchers for their predictions on scientific advances to watch in the coming year. Look for their tips on what's next in cancer immunotherapy, precision oncology, gene editing, infectious disease research, cancer prevention and more.
Tags: Anne McTiernan, antibiotic resistance, Barry L Stoddard, Basic Sciences, Cancer etiology - prevention - outcomes, Clinical Research, Eric Holland, gene editing, gene therapy, Human Biology, hutch data commonwealth, immunotherapy, Jennifer Adair, Johanna W Lampe, Jonathan A Cooper, Jonathan Bricker, Martin Cheever, Matthew Trunnell, Molecular basis of cancer , Peter Nelson, Philip D Greenberg, Polly A Newcomb, Public Health Sciences, Scott Ramsey, shared resources, Steven Pergam, Transplant and Immunotherapy, Trevor Bedford, Vaccine and Infectious Disease, Vaccine development - Viral cancers
10 highlights of Fred Hutch science in 2017
A look back at notable discoveries in cancer immunotherapy, HIV prevention and more
Dec. 28, 2017 | by Sabin Russell and Susan Keown / Fred Hutch News Service
It's been a year of breakthroughs at Fred Hutch. Here are 10 of our favorites.
Tags: aspirin, Bezos, bioengineering, Breast Cancer, Cameron Turtle, Cancer etiology - prevention - outcomes, CAR t-cell, Clinical Research, Colorectal Cancer, genome, hiv, hiv vaccine, hiv vaccine trials network, Human Biology, immunology, Jason Bielas, Lawrence Corey, Matthias Stephan, merkel cell carcinoma, metastasis, Molecular basis of cancer , mylotarg, Obliteride, Paul Nghiem, philanthropy, Polly A Newcomb, Public Health Sciences, RNA, Ruth Etzioni, Soheil Meshinchi, Steven Henikoff, Transplant and Immunotherapy, Tumor specific translational research, Vaccine and Infectious Disease, Vaccine development - Viral cancers
Good News at Fred Hutch
Celebrating faculty and staff achievements
Oct. 26, 2017
Fred Hutch leader Dr. Gary Gilliland addressed lawmakers at a hearing to discuss NIH funding for biomedical research, particularly the role of a type of funding called facilities and administrative costs.
Tags: Basic Sciences, Cancer etiology - prevention - outcomes, Cancer Prevention Program, D. Gary Gilliland, funding sources, Good News, human proteome, immunotherapy, Linda Buck, olfactory system, Polly A Newcomb, Public Health Sciences, Sarcoma, Seth Pollack, Steven Henikoff, Transplant and Immunotherapy
(RSS feeds are best viewed in browsers other than Chrome)
Editor's Picks
Immune booster may awaken body's defenses against skin cancer
Persistent HIV infection works a lot like cancer, study shows
Squelching ovarian cancer: the not-so-silent killer
GIVE NOW &
SAVE LIVES
Story Archive
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
Publications
Magazine Archive
Back issues of Hutch Magazine
Financial Reporting
Fiscal highlights & Annual Reports
Science Spotlight
Monthly review of Center-authored papers
Fred Hutch News
Get updates via email.
